Veradigm | MDRX - Pre Tax Profit


Veradigm reported $35.3M in Pre-Tax Profit for its fiscal quarter ending in September of 2022.





Pre Tax Profit Change Date
Ambu A/S DKK 157M 4M Mar/2026
Amplifon EUR 23.22M 3.12M Mar/2026
Cardinal Health USD 630M 32M Dec/2025
Centene USD 2.1B 3.64B Mar/2026
Charles River Laboratories USD -294.1M 464.13M Dec/2025
Cigna USD 1.82B 478M Dec/2025
Coloplast 1.79B 236M Dec/2025
Convatec Group USD 52M 6.3M Jun/2024
CVS Health USD 3.94B 2.58B Mar/2026
Diasorin EUR 62M 11.45M Mar/2026
Elevance Health USD 215M 1.19B Dec/2025
General Electric Aerospace USD 2.2B 654M Mar/2026
Humana USD -1.01B 1.54B Dec/2025
IQVIA Holdings USD 6.22B 5.68B Mar/2026
Laboratory Of America USD 8.73B 8.54B Mar/2026
Maximus USD 126.53M 267K Mar/2026
McKesson USD 1.63B 235M Dec/2025
Med Life RON 11.88M 28.54M Sep/2025
Molina Healthcare USD 29M 243M Mar/2026
Omnicell USD 699K 9M Dec/2025
Oriola-kd EUR 2.2M 7.8M Sep/2025
Owens Minor USD 35.71M 5.37M Sep/2025
Quest Diagnostics USD 334M 4M Mar/2026
Rede D'or Sao Luiz BRL 1.42B 74.95M Mar/2026
Siemens Healthineers EUR 603M 133M Dec/2025
Sonova Holding CHF 234.3M 159.4M Dec/2025
Supermax Corporation Bhd MYR -39.65M 103.39M Mar/2026
UnitedHealth USD -720M 3.95B Dec/2025
Veeva Systems USD 469.79M 152.26M Mar/2026
Veradigm USD 35.3M 13.95M Sep/2022
Xerox USD 299M 145M Mar/2026